Neurological comorbidities and COVID-19-related case fatality: A cohort study

Alberto Romagnolo1, Gabriele Imbalzano1, Carlo Alberto Artusi1

  • 1Department of Neuroscience "Rita Levi Montalcini", University of Turin, Turin, Italy; SC Neurologia 2U, AOU Città della Salute e della Scienza, Turin, Italy.

Insights

Pre-existing neurological conditions, especially neurodegenerative diseases, significantly increase the risk of death from Coronavirus disease-2019 (COVID-19). These findings highlight the need for prioritized screening, care, and vaccination for neurological patients.

Area of Science:

  • Neurology
  • Infectious Diseases
  • Public Health

Background:

  • Neurological involvement is a known complication of Coronavirus disease-2019 (COVID-19).
  • The impact of pre-existing neurological conditions on COVID-19 mortality remains under investigation.
  • This study examines the case fatality rate (CFR) in COVID-19 patients with prior neurological diagnoses.

Purpose of the Study:

  • To assess the association between pre-existing neurological diseases and COVID-19 related mortality.
  • To compare the CFR and survival outcomes in COVID-19 patients with and without neurological comorbidities.

Main Methods:

  • Retrospective cohort study of 332 COVID-19 patients admitted between March-April 2020.
  • Multivariate regression analysis to determine the association between neurological diseases and mortality.
  • Propensity score matching (1:1) to compare CFR and survival curves between neurological and non-neurological patient groups.

Main Results:

  • Patients with pre-existing neurological disease (22.6%) had a significantly increased risk of COVID-19 mortality (OR: 2.559, p < 0.017).
  • The overall CFR was double in patients with neurological conditions (48.0% vs. 24.0%, p = 0.002).
  • Neurodegenerative diseases showed a significantly higher CFR (73.9% vs. 39.1%, p = 0.017), while cerebrovascular diseases did not reach statistical significance.

Conclusions:

  • Pre-existing neurological comorbidities, particularly neurodegenerative diseases, substantially increase COVID-19 case fatality.
  • These findings underscore the critical need for prioritized screening, healthcare access, and vaccination for individuals with neurological conditions.
Abstract

Related Concept Videos

COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
746
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
128
Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:  
844
Prevalence and Incidence01:08

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
1.0K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
51
Causality in Epidemiology01:21

Causality in Epidemiology

Causality or causation is a fundamental concept in epidemiology, vital for understanding the relationships between various factors and health outcomes. Despite its importance, there's no single, universally accepted definition of causality within the discipline. Drawing from a systematic review, causality in epidemiology encompasses several definitions, including production, necessary and sufficient, sufficient-component, counterfactual, and probabilistic models. Each has its strengths and...
1.1K